Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-34.34	52.23	79.56
Graham Fair Price	47.35	13.83	9.39
PEG	-89.12	0.19	-1.75
Price/Book	4.38	5.56	5.33
Price/Cash Flow	47.01	213.90	145.50
Prices/Earnings	-56.01	23.90	54.34
Price/Sales	-5.31	16.43	17.35
Price/FCF	47.01	213.90	145.50
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.92	0.75	0.81
Operating Margin	149.38	0.26	0.10
ROA	124.37	0.02	< 0.005
ROE	0.02	0.06	137.27
ROIC	0.02	0.04	82.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.21	< 0.005	12768.42
Dividends QOQ	-1.00	1515.50	151665.27
EBIT QOQ	-0.37	1.63	342.27
EPS QOQ	-0.31	1.26	304.38
FCF QOQ	-0.36	-0.32	10.49
Revenue QOQ	0.05	0.05	17.67
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	211.51	152.83	-27.74
Days Sales Outstanding (DSO)	101.44	86.78	-14.45
Inventory Turnover	0.43	0.59	38.40
Debt/Capitalization	0.42	0.47	11.95
Quick Ratio	0.64	0.70	10.22
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.63	12.09	-4.34
Cash	1.89	2.59	36.88
Capex	-0.31	-0.52	-69.66
Free Cash Flow	0.46	0.31	-32.08
Revenue	3.88	4.09	5.45
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.82	0.89	7.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.83	5.94	-24.21
Naive Interpretation	Member

06 - Financial Health · Bad

Rating